Puma Biotechnology Inc (PBYI) Financials

PBYI Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 230.5 million 177.1 million
2023-09-30 203.6 million 164.9 million
2023-06-30 200.5 million 170.1 million
2023-03-31 196.3 million 170.4 million

PBYI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 10.4 million 2.4 million
2023-09-30 10.6 million 2.5 million
2023-06-30 3.2 million 2.4 million
2023-03-31 -9.9 million 2.8 million

PBYI Net Income

No data available :(

PBYI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 95.9 million - 11.8 million
2023-09-30 85.0 million - 12.9 million
2023-06-30 74.4 million - 14.0 million
2023-03-31 71.2 million - 15.0 million

PBYI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 48.0 million
2023-09-30 47.8 million
2023-06-30 47.2 million
2023-03-31 47.2 million

PBYI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 45000 12.9 million 19.8 million 367000
2023-09-30 27000 11.4 million 22.2 million -
2023-06-30 68000 13.4 million 24.5 million -
2023-03-31 12.5 million 12.7 million 22.5 million -

PBYI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 72.2 million 24.3 million
2023-09-30 56.1 million 13.3 million
2023-06-30 54.6 million 11.9 million
2023-03-31 52.8 million 13.2 million

PBYI

Price: $4.95

52 week price:
2.13
7.73

Earnings Per Share: 0.45 USD

P/E Ratio: 72

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 234700

Ebitda: -76.5 million

Market Capitalization: 272.9 million

Links: